We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$368M
AUM Growth
+$17.6M
Cap. Flow
-$11.6M
Cap. Flow %
-3.15%
Top 10 Hldgs %
39.61%
Holding
168
New
6
Increased
49
Reduced
57
Closed
23

Top Buys

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$3.27M
2
DIS icon
Walt Disney
DIS
+$3.04M
3
XLNX
Xilinx Inc
XLNX
+$1.73M
4
ZBH icon
Zimmer Biomet
ZBH
+$833K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$655K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.96M
2
AAPL icon
Apple
AAPL
+$1.91M
3
MSFT icon
Microsoft
MSFT
+$1.75M
4
ADSK icon
Autodesk
ADSK
+$1.66M
5
AMZN icon
Amazon
AMZN
+$1.41M

Sector Composition

Rank Sector Weight
1 Technology 26.51%
2 Healthcare 17.25%
3 Consumer Discretionary 12.52%
4 Consumer Staples 11.07%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADBE icon
26
Adobe
ADBE
$99.5B
$4.36M 1.18%
7,442
-304
-4% -$157K
HON icon
27
Honeywell
HON
$77B
$4.24M 1.15%
20,491
+203
+1% +$42.9K
CHD icon
28
Church & Dwight Co
CHD
$23.4B
$4.13M 1.12%
48,443
+2,505
+5% +$217K
PEP icon
29
PepsiCo
PEP
$190B
$4.12M 1.12%
27,822
-1,851
-6% -$270K
WMT icon
30
Walmart Inc
WMT
$885B
$4M 1.09%
85,101
-2,073
-2% -$96.6K
XLNX
31
DELISTED
Xilinx Inc
XLNX
$3.78M 1.03%
28,254
+13,577
+93% +$1.73M
NEOG icon
32
Neogen
NEOG
$2.62B
$3.75M 1.02%
81,554
-5,104
-6% -$236K
CVX icon
33
Chevron
CVX
$392B
$3.67M 1%
35,067
+1,857
+6% +$196K
HSY icon
34
Hershey
HSY
$35.5B
$3.48M 0.95%
20,000
– –
SGEN
35
DELISTED
Seagen Inc. Common Stock
SGEN
$3.45M 0.94%
21,852
-323
-1% -$48K
PM icon
36
Philip Morris
PM
$297B
$3.22M 0.88%
32,490
-1,983
-6% -$190K
MRK icon
37
Merck
MRK
$322B
$3.15M 0.86%
40,484
-3,452
-8% -$257K
UNP icon
38
Union Pacific
UNP
$174B
$2.63M 0.71%
11,959
+1,220
+11% +$272K
NVO
39
Novo Nordisk
NVO
$208B
$2.37M 0.64%
56,592
-1,400
-2% -$54.3K
IFF icon
40
International Flavors & Fragrances
IFF
$20.2B
$2.22M 0.6%
14,845
-2,300
-13% -$330K
AVGO icon
41
Broadcom
AVGO
$1.85T
$2.09M 0.57%
43,740
-3,700
-8% -$171K
TMO icon
42
Thermo Fisher Scientific
TMO
$213B
$2.08M 0.57%
4,122
+117
+3% +$55.2K
MMM icon
43
3M
MMM
$90.9B
$2.06M 0.56%
12,431
-802
-6% -$134K
AXP icon
44
American Express
AXP
$227B
$1.92M 0.52%
11,625
– –
LMT icon
45
Lockheed Martin
LMT
$134B
$1.91M 0.52%
5,058
-407
-7% -$156K
T icon
46
AT&T
T
$159B
$1.74M 0.47%
80,078
+1,111
+1% +$25.3K
NTR icon
47
Nutrien
NTR
$33.2B
$1.7M 0.46%
27,958
+2,636
+10% +$156K
CSCO icon
48
Cisco
CSCO
$457B
$1.68M 0.46%
31,631
– –
ZBH icon
49
Zimmer Biomet
ZBH
$18.2B
$1.64M 0.45%
10,549
+5,140
+95% +$833K
INTU icon
50
Intuit
INTU
$86.5B
$1.63M 0.44%
3,319
-250
-7% -$108K
1
2
3 4 5

Similar funds

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Fairfield, Bush & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Fairfield, Bush & Co held 168 positions worth $368M, up 5% from $350M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Fairfield, Bush & Co withdrew a net $11.6M in Q2 2021, closing 23 positions and reducing 57 holdings. Its most notable exit was Biogen, an estimated $1.96M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Fairfield, Bush & Co opened a new position in Albemarle worth $628K.

  • Fairfield, Bush & Co's largest Q2 2021 buy was Albemarle: 3,730 shares worth $628K.
  • Fairfield, Bush & Co added most to iShares 1-3 Year Treasury Bond ETF in Q2 2021, an estimated $3.27M increase.
  • Fairfield, Bush & Co's biggest Q2 2021 reduction was Apple, cutting an estimated $1.91M.
  • Fairfield, Bush & Co fully exited Biogen in Q2 2021, selling an estimated $1.96M.
  • Fairfield, Bush & Co's ten largest holdings make up 40% of its $368M portfolio in Q2 2021.
  • Fairfield, Bush & Co opened 6 new positions and closed 23 in Q2 2021.
  • Fairfield, Bush & Co's portfolio value rose 5% quarter-over-quarter to $368M.

Based on Fairfield, Bush & Co's 13F filing for Q2 2021, filed 2 Aug 2021.